Total Synthesis, Stereochemical Assignment, and Biological Activity of All Known (−)-Trigonoliimines
Author(s)
Han, Sunkyu; Morrison, Karen C.; Hergenrother, Paul J.; Movassaghi, Mohammad
DownloadMovassaghi_Total synthesis.pdf (1.214Mb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
A full account of our concise and enantioselective total syntheses of all known (−)-trigonoliimine alkaloids is described. Our retrobiosynthetic analysis of these natural products enabled identification of a single bistryptamine precursor as a precursor to all known trigonoliimines through a sequence of transformations involving asymmetric oxidation and reorganization. Our enantioselective syntheses of these alkaloids enabled the revision of the absolute stereochemistry of (−)-trigonoliimines A, B, and C. We report that trigonoliimines A, B, C and structurally related compounds showed weak anticancer activities against HeLa and U-937 cells.
Date issued
2013-10Department
Massachusetts Institute of Technology. Department of ChemistryJournal
Journal of Organic Chemistry
Publisher
American Chemical Society (ACS)
Citation
Han, Sunkyu, Karen C. Morrison, Paul J. Hergenrother, and Mohammad Movassaghi. “Total Synthesis, Stereochemical Assignment, and Biological Activity of All Known (−)-Trigonoliimines.” The Journal of Organic Chemistry 79, no. 2 (January 17, 2014): 473–486.
Version: Author's final manuscript
ISSN
0022-3263
1520-6904